Content equals the label
Purity (%) and content (the actual amount delivered) are not the same thing. We document both, so the amount on the label is the amount you receive — no quiet shortfalls.
B2B Retatrutide / LY3437943 lyophilized peptide vial supply for qualified buyers, with documentation review, traceability, custom fill quantity, and packaging discussion.
Key Review Snapshot
Why buyers trust WUMO
In this market, “99% pure” is often quoted while the amount actually delivered is far less. We keep purity and real content separate, and put both on paper — so Retatrutide / LY3437943 Lyophilized Peptide Vial Supplier is backed by documents you can check.
Research peptide line — typical purity >99.3–99.4%, every batch MS-checked before release.
Purity (%) and content (the actual amount delivered) are not the same thing. We document both, so the amount on the label is the amount you receive — no quiet shortfalls.
Identity and quality are confirmed by batch documentation — COA, plus HPLC / MS where applicable — before material is released.
Ingredient identity (INCI / CAS), specification sheet and SDS are available for review. Match the documents to your quoted batch before you commit.
Documents Available
COA
Batch-level quality summary for buyer-side file review.
COA
Batch-level quality summary for buyer-side file review.
COA
Batch-level quality summary for buyer-side file review.
Analytical File
Purity profile reference for the quoted project or batch where available.
Request this analytical file through the inquiry path below.
Analytical File
Identity confirmation support for documentation review where available.
Request this analytical file through the inquiry path below.
Safety Document
Safety document requested for internal purchasing and handling review.
Request this safety document through the inquiry path below.
Overview
Retatrutide / LY3437943 is listed here as a lyophilized peptide vial supply item for qualified B2B sourcing projects. WUMO Peptide supports business buyers that need documentation review, batch traceability, packaging discussion, and supply feasibility confirmation before procurement planning.
Batches are supported by analytical verification — purity assessed by RP-HPLC (above 99% on current batches) and identity confirmed by ESI-TOF mass spectrometry — with batch-specific COA, HPLC, and MS reports provided to qualified buyers on request.
This page is not a direct-to-consumer retail page. It is designed for qualified business buyers, distributors, labs, OEM/ODM teams, formulation developers, and legally authorized importers.
All technical information is subject to batch-specific COA and project confirmation.
B2B Review Guide
Retatrutide, also known as LY3437943, can be discussed as a lyophilized peptide vial project where documentation, batch consistency, sourcing transparency, and project-specific specifications are required. WUMO supports business-side evaluation, document checks, packaging planning, and supply discussions based on buyer qualification, destination market, and applicable import or distribution expectations.
| Item | Information |
|---|---|
| Product Name | Retatrutide, subject to batch-specific COA and project confirmation |
| Alternative Name | LY3437943, subject to batch-specific COA and project confirmation |
| CAS Number | 2381089-83-2, subject to batch-specific COA and project confirmation |
| Molecular Formula | C221H342N46O68, subject to batch-specific COA and project confirmation |
| Molecular Weight | 4731.34, subject to batch-specific COA and project confirmation |
| Product Format | Lyophilized peptide vial |
| Supply Focus | B2B peptide vial supply and project-based sourcing |
| Documentation | COA, HPLC, MS, SDS/MSDS, and batch traceability records where available |
WUMO focuses on documentation-driven supply for B2B peptide projects. For Retatrutide / LY3437943 lyophilized peptide vial projects, available quality documentation may include batch-specific COA, HPLC report, MS report, SDS/MSDS, and traceability information. Documentation scope may vary by batch, project type, packaging arrangement, and buyer requirements.
Request B2B Project Review. Share your target fill quantity, packaging preference, documentation requirements, destination market, and estimated order volume. WUMO Peptide will review your project and provide supply feasibility, MOQ, lead time, and documentation guidance.
Retatrutide / LY3437943 information on this page is provided for qualified B2B sourcing, documentation review, and project discussion only. This page is not intended for direct consumer sale or individual product-use guidance. WUMO Peptide does not provide medical guidance, disease-related claims, or end-user outcome claims. All technical information is subject to batch-specific COA and project confirmation.
OEM / Private Label
For finished lyophilized peptide vials with custom labels and packaging -- covering MOQ, sample or pilot evaluation, and batch documentation such as COA, sterility, and endotoxin reports -- see our private label peptide vial (OEM / ODM) service.
For qualified B2B sourcing only. Share your destination market, required documents, packaging format, and quotation unit.
Need COA, SDS/MSDS, or specifications? Choose "Technical document request" in the inquiry form or mention the file name in your message.